{
    "id": "dbpedia_8099_0",
    "rank": 66,
    "data": {
        "url": "https://www.pharmacompass.com/pipeline-prospector-drugs-in-development/jiangsu-simcere-pharmaceutical",
        "read_more_link": "",
        "language": "en",
        "title": "Jiangsu Simcere Pharmaceutical",
        "top_image": "https://www.pharmacompass.com/image/logo/pipeline_prospector_logo.jpg",
        "meta_img": "https://www.pharmacompass.com/image/logo/pipeline_prospector_logo.jpg",
        "images": [
            "https://www.pharmacompass.com/image/flap/abbvie-corp-adgif-27965.gif",
            "https://www.pharmacompass.com/image/flap/abbvie-corp-ad-w33-mob-headergif-39012.gif",
            "https://www.pharmacompass.com/image/pc-logo-star-orange-gradient-blue-bg-final-100x100.png",
            "https://www.pharmacompass.com/image/vb/menu-dropdown-white.png",
            "https://www.pharmacompass.com/image/vb/MP-Icon-100x100.png",
            "https://www.pharmacompass.com/image/vb/post-enquiry-icon-100x100.png",
            "https://www.pharmacompass.com/image/pc-logo-star-orange-gradient-blue-bg-final-100x100.png",
            "https://www.pharmacompass.com/image/vb/menu-dropdown-white.png",
            "https://www.pharmacompass.com/image/ASK_US_Button.gif",
            "https://www.pharmacompass.com/image/icons/MP-Icon.png",
            "https://www.pharmacompass.com/image/pc-logo-star-orange-gradient-blue-bg-final-100x100.png",
            "https://www.pharmacompass.com/image/vb/menu-dropdown-white.png",
            "https://www.pharmacompass.com/image/vb/menu-dropdown-white.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-200x200.png",
            "https://www.pharmacompass.com/assets/css/images/Loader.gif",
            "https://www.pharmacompass.com/image/vb/left-arrow-grey.png",
            "https://www.pharmacompass.com/image/vb/right-arrow-grey.png",
            "https://www.pharmacompass.com/image/vb/empty-filter-icon-256.png",
            "https://www.pharmacompass.com/image/vb/filter-i-orange.png",
            "https://www.pharmacompass.com/image/vb/filter-i-orange.png",
            "https://www.pharmacompass.com/image/vb/filter-i-orange.png",
            "https://www.pharmacompass.com/image/vb/filter-i-orange.png",
            "https://www.pharmacompass.com/image/vb/filter-i-orange.png",
            "https://www.pharmacompass.com/image/button-icons/Filter-Blue-filled-100.png",
            "https://www.pharmacompass.com/image/button-icons/Filters-Ghost.png",
            "https://www.pharmacompass.com/image/button-icons/Filter-Blue-filled-100.png",
            "https://www.pharmacompass.com/image/button-icons/pp-icon-4.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Development-Updates-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Development-Updates-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Deals-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Deals-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Deals-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Development-Updates-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Deals-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Development-Updates-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Deals-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/vb/envelope_access.png",
            "https://www.pharmacompass.com/image/vb/Development-Updates-blue.png",
            "https://www.pharmacompass.com/image/vb/vb-orange-btn.png",
            "https://www.pharmacompass.com/image/vb/post-enquiryx100-pc-blue.png",
            "https://www.pharmacompass.com/image/logo/jiangsu-simcere-pharmaceutical.png",
            "https://www.pharmacompass.com/image/button-icons/Google-Map-1.png",
            "https://www.pharmacompass.com/image/vb/vb-pc-blue-btn-100x100.png",
            "https://www.pharmacompass.com/image/button-icons/Digital-Content-Icon.png",
            "https://www.pharmacompass.com/image/pc-blue-orange-logo-star-100x100.png",
            "https://www.pharmacompass.com/image/ads250/moehs-iberica-5560.gif",
            "https://www.pharmacompass.com/image/ads250/chemwerth-inc-m-75406.gif",
            "https://www.pharmacompass.com/image/linkedin_ln.png",
            "https://www.pharmacompass.com/image/message icon.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Jiangsu Simcere Pharmaceutical",
            "Drug Developments",
            "Pipeline Prospector",
            "drugs database by Jiangsu Simcere Pharmaceutical"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Jiangsu Simcere Pharmaceutical",
        "meta_lang": "en",
        "meta_favicon": "https://www.pharmacompass.com/image/favicon.ico",
        "meta_site_name": "PharmaCompass.com",
        "canonical_link": "https://www.pharmacompass.com/pipeline-prospector-drugs-in-development/jiangsu-simcere-pharmaceutical",
        "text": "Details:\n\nEnlituo (cetuximab beta) is a EGFR inhibitor indicated in combination with the FOLFIRI regimen as a first-line treatment for RAS/BRAF wild-type metastatic colorectal cancer (mCRC).\n\nLead Product(s): Cetuximab,Irinotecan Hydrochloride,Calcium Folinate\n\nTherapeutic Area: Oncology Product Name: Enlituo\n\nHighest Development Status: Approved Product Type: Large molecule\n\nPartner/Sponsor/Collaborator: Not Applicable\n\nDeal Size: Not Applicable Upfront Cash: Not Applicable\n\nDeal Type: Not Applicable June 26, 2024\n\nDetails:\n\nSanbexin (a combination of edaravone and dexborneol) is a small molecule, sublingual tablet, which is being evaluated for the treatment of acute ischemic stroke.\n\nLead Product(s): Edaravone,Dexborneol\n\nTherapeutic Area: Neurology Product Name: Sanbexin\n\nHighest Development Status: Phase III Product Type: Small molecule\n\nPartner/Sponsor/Collaborator: Neurodawn Pharmaceutical\n\nDeal Size: Not Applicable Upfront Cash: Not Applicable\n\nDeal Type: Not Applicable February 20, 2024\n\nDetails:\n\nUnder the agreement, Simcere will develop and commercialize Connect Biopharma’s CBP-201 (rademikibart), a human monoclonal antibody against IL-4Rα, in Greater China.\n\nLead Product(s): Rademikibart\n\nTherapeutic Area: Dermatology Product Name: CBP-201\n\nHighest Development Status: Phase III Product Type: Large molecule\n\nRecipient: Connect Biopharma\n\nDeal Size: $141.0 million Upfront Cash: $21.0 million\n\nDeal Type: Licensing Agreement November 21, 2023\n\nDetails:\n\nThe agreement aims to establish a mutually beneficial partnership that will advance scientific research and create new treatment options for patients with cancer, autoimmune and CNS diseases.\n\nLead Product(s): Undisclosed\n\nTherapeutic Area: Oncology Product Name: Undisclosed\n\nHighest Development Status: Discovery Product Type: Undisclosed\n\nPartner/Sponsor/Collaborator: Mass General Brigham\n\nDeal Size: Undisclosed Upfront Cash: Undisclosed\n\nDeal Type: Agreement June 12, 2023\n\nDetails:\n\nUnder the agreement, MSD will supply KEYTRUDA and collaborate with Simcere to evaluate the combination of SIM0235, a potential first-in-class humanized anti-TNFR2 mAb, and MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in patients with advanced solid tumors and CTCL.\n\nLead Product(s): SIM0235,Pembrolizumab\n\nTherapeutic Area: Oncology Product Name: SIM0235\n\nHighest Development Status: Phase I Product Type: Large molecule\n\nPartner/Sponsor/Collaborator: Merck & Co\n\nDeal Size: Undisclosed Upfront Cash: Undisclosed\n\nDeal Type: Collaboration March 14, 2023\n\nDetails:\n\nXIANNUOXIN is a combination packaged drug of a small molecule anti- SARS-CoV-2 drug candidate SSD8432 and Ritonavir, this candidate is targeted 3CL protease which is essential for SARS-CoV-2 viral replication.\n\nLead Product(s): SSD8432,Ritonavir\n\nTherapeutic Area: Infections and Infectious Diseases Product Name: Xiannuoxin\n\nHighest Development Status: Phase II/ Phase III Product Type: Small molecule\n\nPartner/Sponsor/Collaborator: Not Applicable\n\nDeal Size: Not Applicable Upfront Cash: Not Applicable\n\nDeal Type: Not Applicable December 20, 2022\n\nDetails:\n\nUnder the agreement, Simcere will be granted an exclusive right to develop and commercialize daridorexant (ACT-541468) in the Greater China region (Mainland China, Hong Kong, and Macau), one of the world's largest pharmaceutical markets.\n\nLead Product(s): Daridorexant\n\nTherapeutic Area: Sleep Product Name: ACT-541468\n\nHighest Development Status: Approved Product Type: Small molecule\n\nRecipient: Idorsia Pharmaceuticals\n\nDeal Size: $50.0 million Upfront Cash: $30.0 million\n\nDeal Type: Licensing Agreement November 16, 2022\n\nDetails:\n\nSIM0237 is an anti-PD-L1 monoclonal antibody fused with potency reduced IL-15/IL-15Rα sushi domain developed in-house by utilizing the Simcere's protein engineering platform. It can block the PD-1/PD-L1 immunosuppressive pathway via binding to PD-L1.\n\nLead Product(s): SIM0237\n\nTherapeutic Area: Oncology Product Name: SIM0237\n\nHighest Development Status: IND Enabling Product Type: Large molecule\n\nPartner/Sponsor/Collaborator: Not Applicable\n\nDeal Size: Not Applicable Upfront Cash: Not Applicable\n\nDeal Type: Not Applicable October 27, 2022\n\nDetails:\n\nCOSELA® (trilaciclib) is indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer.\n\nLead Product(s): Trilaciclib\n\nTherapeutic Area: Oncology Product Name: Cosela\n\nHighest Development Status: Approved Product Type: Small molecule\n\nRecipient: G1 Therapeutics, Inc\n\nDeal Size: $170.0 million Upfront Cash: $14.0 million\n\nDeal Type: Licensing Agreement July 13, 2022"
    }
}